Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Julia E Möhlmann, Amely Mk Daza Zabaleta, Matthijs van Luin, Alferso C Abrahams
Vancomycin has been reported to cause vancomycin flushing reaction (VFR), a hypersensitivity reaction that mostly occurs after intravenous administration. The incidence of VFR in a patient receiving intraperitoneal vancomycin is rare. We report a case of a female peritoneal dialysis (PD) patient with a PD-related peritonitis who developed VFR after intraperitoneal administration of 2000 mg vancomycin. Seventy-five minutes after instillation, she developed flushing, a pruritic erythema on the upper body and swelling of the lips...
September 25, 2023: Peritoneal Dialysis International
#2
REVIEW
Susan J Lewis, Brandon Alves, Shobha Ratnam, Mariann D Churchwell
To optimise antimicrobial administration in patients with peritoneal dialysis (PD)-related peritonitis, healthcare providers need literature-based information to develop patient-centred pharmacotherapeutic plans. Traditional PD solutions promote osmosis using dextrose or icodextrin with a lactate buffer. Newer PD solutions have modified the osmotic vehicle and buffer. Knowledge of antimicrobial compatibility and stability with newer PD solutions will assist with determining the route of antimicrobial administration as compatible and stable solutions could be delivered directly to the peritoneum using intraperitoneal administration...
September 20, 2023: Peritoneal Dialysis International
#3
JOURNAL ARTICLE
Paul Nguyen, Ananthakrishnapuram Aravindan, Jeffrey Wong
No abstract text is available yet for this article.
September 18, 2023: Peritoneal Dialysis International
#4
JOURNAL ARTICLE
Angela S Rivera, Jasmin I Vesga, Sergio Páez, Kindar Astudillo, Andrea Aldana, Yolima Alba, Luz E Niño, Juan C Castillo, Mauricio Sanabria, Bengt Lindholm, Peter Rutherford
BACKGROUND: The first year of dialysis is critical given the significant risk for complications following dialysis initiation. We analysed complications during the first year among incident peritoneal dialysis (PD) patients. METHODS: This retrospective cohort study comprised adult kidney failure patients starting PD in Baxter Renal Care Services in Colombia, receiving their first PD catheter between 1 January 2017 and 31 December 2020 and were followed up for up to 1 year...
September 18, 2023: Peritoneal Dialysis International
#5
JOURNAL ARTICLE
S Veenaa Manjari, Rajeevalochana Parthasarathy, Deepak Kumar Selvanathan, Supriya Dhakshinamoorthy, Sriram Parthasarathy, Shajeev Jaikumar, Sanjeev Nair
No abstract text is available yet for this article.
September 18, 2023: Peritoneal Dialysis International
#6
REVIEW
Raymond T Krediet, Alena Parikova
Long-term peritoneal dialysis is associated with the development of peritoneal membrane alterations, both in morphology and function. Impaired ultrafiltration (UF) is the most important functional change, and peritoneal fibrosis is the major morphological alteration. Both are caused by the continuous exposure to dialysis solutions that are different from plasma water with regard to the buffer substance and the extremely high-glucose concentrations. Glucose has been incriminated as the major cause of long-term peritoneal membrane changes, but the precise mechanism has not been identified...
September 18, 2023: Peritoneal Dialysis International
#7
JOURNAL ARTICLE
Benjamin Briggs, Guillermo Garcia-Garcia, Margarita Ibarra-Hernandez, Luz Alcantar-Vallin, Gary Walker, Eric Yu, Aly ElBadry, Brian Fisher, Don Williamson, Glenn M Chertow
BACKGROUND: The risk of peritonitis has limited wider adoption of peritoneal dialysis (PD) in the United States. We developed a prototype bedside dialysate turbidity monitoring system, aiming to improve diagnostic accuracy relative to conventional approaches which depend on visual inspection and reporting of insensitive and non-specific symptoms. METHODS: The prototype system was tested in a single-centre, proof-of-principle clinical study in patients receiving intermittent PD...
September 18, 2023: Peritoneal Dialysis International
#8
JOURNAL ARTICLE
Piyumi Wijewickrama, Michael Onyema, Hatem Eid, Natalie Phare, Jonathan Dick, Dimitrios Moutzouris, Mark Lambie, Prashant Vas, Jennifer Williams, Janaka Karalliedde
There is limited data on the standards of diabetes care in people on peritoneal dialysis (PD). Our aim was to assess the standards of diabetes care and the burden of hypoglycaemia in people with diabetes on PD. We performed a retrospective study at three university hospitals from December 2021 to January 2022. Clinical data were extracted from electronic health records. Diabetes care of people on PD was compared against recommended standards for people with diabetes on haemodialysis (as there are no agreed standards for PD)...
September 13, 2023: Peritoneal Dialysis International
#9
JOURNAL ARTICLE
José E Navarrete, Oyintayo Ajiboye, Janice I Lea
BACKGROUND: Hyperphosphataemia is a common complication of kidney disease. Current dialysis techniques do not provide enough phosphorus clearance, hence the need to use phosphorus binders. Treatment options include calcium carbonate, calcium acetate, lanthanum carbonate, sevelamer hydrochloride and iron-based binders. Patients receiving peritoneal dialysis (PD) with sustained elevated ferritin levels exceeding 800 ng/mL are at a higher risk of death. We identify PD patients treated with iron-based binders and compare ferritin and risk of iron accumulation to patients treated with non-iron-based binders...
September 10, 2023: Peritoneal Dialysis International
#10
JOURNAL ARTICLE
Somchai Chaichayanon, Athiphat Banjongjit, Talerngsak Kanjanabuch, Jeffrey Perl
No abstract text is available yet for this article.
September 10, 2023: Peritoneal Dialysis International
#11
JOURNAL ARTICLE
Kanin Thammavaranucupt, Watthikorn Pichitporn, Watanyu Parapiboon, Laddaporn Wongluechai, Suppachok Kirdlarp, Talerngsak Kanjanabuch
No abstract text is available yet for this article.
September 10, 2023: Peritoneal Dialysis International
#12
JOURNAL ARTICLE
Henco Nel, Fortnum Debbie, Hawkins Narelle, Randall Sean, Chakera Aron
BACKGROUND: Assisted peritoneal dialysis (aPD) represents an alternative kidney replacement therapy for dialysis-dependent patients whose only other options are prolonged hospitalisations or transfer to in-centre haemodialysis (HD). Most programmes have not examined the role of temporary aPD, and there is limited data surrounding the economic implications of temporary aPD programmes. The main aim of this study was to describe the cost-effectiveness of an assisted automated peritoneal dialysis (aAPD) programme, for patients whose only reason to stay in hospital was the temporary inability to independently perform PD at home...
August 27, 2023: Peritoneal Dialysis International
#13
JOURNAL ARTICLE
Tsutomu Sakurada, Shigeki Kojima, Shohei Yamada, Kenichiro Koitabashi, Yasuhiro Taki, Katsuomi Matsui, Masaru Murasawa, Hiroo Kawarazaki, Sayaka Shimizu, Hironori Kobayashi, Toshihiro Asai, Koji Hashimoto, Taro Hoshino, Seita Sugitani, Tomochika Maoka, Akihiko Nagase, Hirotaka Sato, Kosuke Fukuoka, Tadashi Sofue, Kiyoto Koibuchi, Kiyomitsu Nagayama, Naoki Washida, Shigehisa Koide, Takayuki Okamoto, Daisuke Ishii, Satoshi Furukata, Kiyotaka Uchiyama, Shunsuke Takahashi, Yoshiko Nishizawa, Shotaro Naito, Naohiro Toda, Tsukasa Naganuma, Hidetoshi Kikuchi, Tomo Suzuki, Daisuke Komukai, Takahide Kimura, Hiroaki Io, Kazuhiro Yoshikawa, Toshihide Naganuma, Masamitsu Morishita, Jin Oshikawa, Keiichi Tamagaki, Hajime Fujisawa, Atsushi Ueda, Tomohiko Kanaoka, Hironori Nakamura, Mai Yanagi, Takashi Udagawa, Tatsuo Yoneda, Masashi Sakai, Masanobu Gunji, Shinichi Osaki, Hisako Saito, Yuuki Yoshioka, Nagayuki Kaneshiro
BACKGROUND: This multi-institutional, observational study examined whether the outcomes after peritoneal dialysis (PD) catheter placement in Japan meet the audit criteria of the International Society for Peritoneal Dialysis (ISPD) guideline and identified factors affecting technique survival and perioperative complications. METHODS: Adult patients who underwent first PD catheter placement for end-stage kidney disease between April 2019 and March 2021 were followed until PD withdrawal, kidney transplantation, transfer to other facilities, death, 1 year after PD start or March 2022, whichever came first...
August 26, 2023: Peritoneal Dialysis International
#14
JOURNAL ARTICLE
Esther Nuñez-Durán, Jessica Westlund, Deman Najar, Kerstin Ebefors
BACKGROUND: Patients with end-stage kidney disease (ESKD) require dialysis or transplantation for their survival. There are few experimental animal models mimicking the human situation in which the animals are dependent on dialysis for their survival. We developed a peritoneal dialysis (PD) system for rats to enable long-term treatment under controlled conditions. METHOD: Rats were chemically nephrectomised using orellanine to render them uremic. Two studies were performed, the first with highly uremic rats on PD for 5 days, and the other with moderately uremic rats on PD for 21 days...
August 17, 2023: Peritoneal Dialysis International
#15
EDITORIAL
Robert Carlson, Karine E Manera
No abstract text is available yet for this article.
August 17, 2023: Peritoneal Dialysis International
#16
(no author information available yet)
No abstract text is available yet for this article.
August 11, 2023: Peritoneal Dialysis International
#17
JOURNAL ARTICLE
Taro Ozaki, Hai Ying Fu, Keisuke Onishi, Shota Yokoyama, Takuro Fujita, Atsushi Tobiume, Tadashi Sofue, Kazuya Akimitsu, Tetsuo Minamino
BACKGROUND: Peritoneal dialysis (PD) is a crucial dialysis method for treating end-stage kidney disease. However, its use is restricted due to high glucose-induced peritoneal injury and hyperglycaemia, particularly in patients with diabetes mellitus. In this study, we investigated whether partially replacing d-glucose with the rare sugar d-allose could ameliorate peritoneal injury and hyperglycaemia induced by peritoneal dialysis fluid (PDF). METHODS: Rat peritoneal mesothelial cells (RPMCs) were exposed to a medium containing d-glucose or d-glucose partially replaced with different concentrations of d-allose...
July 31, 2023: Peritoneal Dialysis International
#18
JOURNAL ARTICLE
Yu-Hui Zhang, Xiao Xu, Hai-Chen Pi, Zhi-Kai Yang, David W Johnson, Jie Dong
OBJECTIVE: Peritoneal dialysis (PD)-related peritonitis is independently associated with low serum 25-hydroxy vitamin D [25(OH)D] levels. Our objective is to examine the feasibility of conducting a large, randomised controlled trial to determine the effects of vitamin D supplementation on the risk of PD-related peritonitis. DESIGN: Pilot, prospective, open-label randomised controlled trial. SETTING: Peking University First Hospital, China...
July 5, 2023: Peritoneal Dialysis International
#19
JOURNAL ARTICLE
Sai Sudha Mannemuddhu, Heather A Morgans, Bradley A Warady
Children with kidney failure who receive maintenance peritoneal dialysis (PD) are at increased risk for thyroid dysfunction. A poorly appreciated cause of hypothyroidism related to PD is iodine overload from exposure to iodine-containing cleaning solutions, iodinated contrast agents or povidone-iodine-containing PD caps, particularly in infants and small children. An international survey was conducted to understand current practices regarding iodine exposure in PD patients, the frequency of iodine-induced hypothyroidism (IIH) in patients receiving PD, and to assess awareness of this issue among paediatric nephrologists...
July 3, 2023: Peritoneal Dialysis International
#20
MULTICENTER STUDY
Melissa S Cheetham, Yeoungjee Cho, Rathika Krishnasamy, Elasma Milanzi, Josephine Chow, Carmel Hawley, Jo-Anne Moodie, Matthew D Jose, Robert MacGinley, Thu Nguyen, Suetonia C Palmer, Rachael Walker, Jeffrey Wong, Arsh K Jain, Neil Boudville, David W Johnson, Louis L Huang
BACKGROUND: Incremental peritoneal dialysis (PD) is increasingly advocated to reduce treatment burden and costs, with potential to better preserve residual kidney function. Global prevalence of incremental PD use is unknown and use in Australia and New Zealand has not been reported. METHODS: Binational registry analysis including incident adult PD patients in Australia and New Zealand (2007-2017), examining incidence of and outcomes associated with incremental PD (first recorded PD exchange volume <42 L/week (incremental) vs...
September 2023: Peritoneal Dialysis International
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
